Preventive PCI versus only optimal medical therapy for vulnerable plaques
Marc Bonaca, MD
Self-assessment on statin eligibility without prescription using a web app
Steven Nissen, MD
Promising results for APOC3 ASO in familial chylomicronemia syndrome
Erik Stroes, MD, PhD
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
Brian Bergmark, MD
Loading...
We’re glad to see you’re enjoying PACE-CME…but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.